Dr. Reddy’s continues sell-off to Neopharma with Hyderabad API plant

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/dima_sideinokov)
(Image: Getty/dima_sideinokov)

Related tags: API, Sales, Manufacturing, Generics, Antibiotics

Dr. Reddy’s Laboratory has decided to sell its API manufacturing plant to generics joint venture, Therapiva.

Dr. Reddy’s decision to sell its active pharmaceutical ingredient (API) manufacturing plant follows the recent sale of the company’s US based manufacturing facility. The sale will include all related fixed assets, current assets, current liabilities and its employees.

Dr. Reddy’s stated that the decision to divest its API manufacturing business unit is a step towards streamlining operations and optimizing costs. The company said that it will allow for a focus on manufacturing generic formulations.

A spokesperson from Dr. Reddy’s told us that from this sale the company is optimistic about realizing meaningful benefits from this transaction. “However, we are not disclosing any specific financials related to anticipated cost savings,” said the spokesperson.

Dr. Reddy’s sold its Tennessee antibiotic manufacturing site to Neopharma​. Omnicare Drugs, one of the buyers of the API plant, is a subsidiary of Neopharma.

The first sale to Neopharma was reported to be an attempt by Dr. Reddy’s to optimize global cost structures. In this sale, the company sold its antibiotics (penicillin) portfolio with the sale of its manufacturing site.

The spokesperson told us that the two transactions are still unrelated despite being sold to the same buyer. Therapiva a joint venture between Omnicare drugs, a Neopharma subsidiary, and Laxai manufacturing.

Related news

Show more

Related products

show more

The battle of performance in pharma production

The battle of performance in pharma production

Telstar Life Science Solutions | 26-Mar-2019 | Case Study

Telstar case study. Discover how a versatile freeze-dryer automatic loading & unloading systemDiscover how a versatile freeze-dryer automatic loading...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers